Fundraising Fox

Decoy Therapeutics

NASDAQ: DCOY

Cambridge, US · Delaware corporation

Biotech

Founders & leadership

BH
Barbara HibnerExecutive
ML
Michael LippExecutive
FE
Frederick Ernest PierceNamed on SEC filing
PK
Peter Klaus MarschelNamed on SEC filing

Funding

SEC filings, press & company announcements

$1.2M disclosed across 1 of 2 rounds · 2025–2026

▶$1.2MraisedJul 2025 · 20 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Barbara HibnerExecutive Officer, Director
  • Frederick Ernest PierceExecutive Officer, Director
  • Michael LippExecutive Officer
  • Peter Klaus MarschelExecutive Officer, Director
Offering amount
$1.2M
Amount sold
$1.2M
Sales commissions
$150K
Placement agents
Craft Capital Management LLC
First sale
Apr 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Decoy Therapeutics Q2 loss widens as cash runway narrows | DCOY Quarterly Report (10-Q)stocktitan.net · Aug 2026Decoy Therapeutics expands IP portfolio to 19 applications By Investing.comca.investing.com · Aug 2026Decoy Therapeutics Secures PIPE Financing to Advance Trials - TipRanks.comtipranks.com · Jun 2026Decoy Therapeutics (NASDAQ: DCOY) lines up $21M milestone-based PIPE fundingstocktitan.net · Jun 2026Decoy Therapeutics' financing can reach $21M if trial milestones hitstocktitan.net · Jun 2026Decoy Therapeutics (NASDAQ: DCOY) details AI antiviral platform, merger and reverse stock splitsstocktitan.net · Mar 2026

Frequently asked questions

How much funding has Decoy Therapeutics raised?
Decoy Therapeutics has disclosed $1.2M raised across 1 of its 2 known rounds.
Where is Decoy Therapeutics headquartered?
Decoy Therapeutics is headquartered in Cambridge, US.